« Back to Record
Stagg, J., Divisekera, U., Ngiow, S. F., Duret, H., Teng, M. W. L. M., Smyth, M. J., Loi, S., & Yagita, H. (2011). Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy. Proceedings of the National Academy of Sciences of the United States of America, 108(17), 7142-7147. doi:10.1073/pnas.1016569108
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195339



